Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.jvsv.2025.102390
Olga Bakayev MD , Paul Tenewitz BS , Aleha Syed BS , Melody Eckert MS , Prayna Bhatia MS , Rielyn Booker MS , Jonathan Mashieh DO , Hiren Walia OMS-III , Natalie Marks MD , Enrico Ascher MD , Anil Hingorani MD
{"title":"Complications in Thermal Ablation Therapies With Diseased Iliac Veins","authors":"Olga Bakayev MD , Paul Tenewitz BS , Aleha Syed BS , Melody Eckert MS , Prayna Bhatia MS , Rielyn Booker MS , Jonathan Mashieh DO , Hiren Walia OMS-III , Natalie Marks MD , Enrico Ascher MD , Anil Hingorani MD","doi":"10.1016/j.jvsv.2025.102390","DOIUrl":"10.1016/j.jvsv.2025.102390","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102390"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.jvsv.2025.102435
Jan Szczepański MD
{"title":"Total Endovenous Laser Ablation With 1940-nm Laser vs 1470-nm Laser: Superior Closure of Truncal Veins and Varicose Tributaries","authors":"Jan Szczepański MD","doi":"10.1016/j.jvsv.2025.102435","DOIUrl":"10.1016/j.jvsv.2025.102435","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102435"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.jvsv.2025.102410
Oscar Moreno MD , Amber Clay RVT, RDCS , Catherine Luke LVT , Sabrina Rocco MS , Kate Micallef MS , Trevin Eggleston BA , Kiran Kumar BS , David Babcock BS , David Gordon MD , Daniel D. Myers DMV, MPH , Thomas Wakefield MD , Peter Henke MD , Andrea Obi MD
{"title":"Novel In Vivo Rethrombosis Model for the Testing of Venoplasty Balloons","authors":"Oscar Moreno MD , Amber Clay RVT, RDCS , Catherine Luke LVT , Sabrina Rocco MS , Kate Micallef MS , Trevin Eggleston BA , Kiran Kumar BS , David Babcock BS , David Gordon MD , Daniel D. Myers DMV, MPH , Thomas Wakefield MD , Peter Henke MD , Andrea Obi MD","doi":"10.1016/j.jvsv.2025.102410","DOIUrl":"10.1016/j.jvsv.2025.102410","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102410"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.jvsv.2025.102417
Ankita Katukota BS
{"title":"Patient-reported Outcomes after Thermal vs Nonthermal Ablation for Treatment of Lower Extremity Superficial Venous Disease","authors":"Ankita Katukota BS","doi":"10.1016/j.jvsv.2025.102417","DOIUrl":"10.1016/j.jvsv.2025.102417","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102417"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.jvsv.2025.102431
Rashad Bishara MD
{"title":"The impact of adjuvant ultrasound-guided peri-ulcer foam sclerotherapy on venous leg ulcer recurrence:. Long-term outcomes of the PUFS trial","authors":"Rashad Bishara MD","doi":"10.1016/j.jvsv.2025.102431","DOIUrl":"10.1016/j.jvsv.2025.102431","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102431"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.jvsv.2025.102437
Shinsuke Akita MD, PhD
{"title":"Treatment Outcomes of Lymphaticovenous Anastomosis for Lower Extremity Lymphedema With Prevention of Venous Reflux","authors":"Shinsuke Akita MD, PhD","doi":"10.1016/j.jvsv.2025.102437","DOIUrl":"10.1016/j.jvsv.2025.102437","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102437"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147396154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-04DOI: 10.1016/j.jvsv.2025.102362
Alexandra Natalie Ascher MD , Enrico Ascher MD , Anil Hingorani MD , John Fang DO
<div><h3>Background</h3><div>Perivenous tumescence with saline or a dilute lidocaine solution is used routinely for thermal ablation of refluxing superficial lower extremity veins to displace sensitive structures away from the thermal probe and provide better contact with the treated venous endothelium. In this study, we introduce an adjunctive technique of tumescence infiltration at the most efferent segment of refluxing saphenous veins treated with 1% polidocanol endovenous microfoam (PEM). We hypothesize that, by reducing the vein diameter, proximal tumescence (PT) prolongs apposition time of PEM to the endothelium by delaying venous outflow and microfoam propagation speed. We evaluated PT effects on vein closure and volume of PEM used as well as the incidence of superficial venous thrombosis and ablation-related thrombus extension (ARTE).</div></div><div><h3>Methods</h3><div>A single institution retrospective study was performed with PEM ablations for the above-knee great saphenous vein (GSV), below-knee GSV, and small saphenous vein (SSV) by two operators over a 12-month period. Duplex ultrasound (DUS) within 3 to 7 days after ablation followed by a serial surveillance DUS schedule were used to evaluate for vein closure, venous thrombosis, and ARTE per institutional protocol. Any treated vein segment found to be completely or partially patent with reflux after treatment was deemed an ablation failure. Demographics and outcomes of tumescent PEM (T-PEM) ablations were compared with nontumescent PEM (NT-PEM) ablations through univariate and generalized estimating equation modeling.</div></div><div><h3>Results</h3><div>Between June 2023 and May 2024, 183 adult patients (64 male, 119 female) treated with 1% PEM in 246 lower extremities (113 right, 133 left) met the study criteria. Nineteen patients without documented follow-up DUS examinations were excluded from this study. Overall, 293 ablations (23 above-knee SV, 199 below-knee GSV, 71 small saphenous vein) were performed with a mean PEM volume of 2.8 ± 0.6 mL per ablation with a combined closure rate of 91.8% (269 of 293). One hundred nineteen ablations (40.6%) were augmented with PT (mean tumescence volume, 6 ± 2.4 mL; range, 3-16 mL). Veins treated with T-PEM were significantly larger (mean vein diameter, 4.8 ± 1.3 mm) than veins treated with NT-PEM (mean vein diameter, 4.0 ± 0.9 mm; <em>P</em> < .001). There were no significant differences in patient age (<em>P</em> = .37), sex (<em>P</em> = .06), laterality (<em>P</em> = .29), preoperative Clinical-Etiology-Anatomy-Pathophysiology clinical severity scores (<em>P</em> = .34), PEM volume used (<em>P</em> = .09), venous thrombosis (<em>P</em> = .65), ARTE (<em>P</em> = .41), or rate of treatment success (<em>P</em> = .16) on univariate comparison of T-PEM and NT-PEM ablations. Generalized estimating equation regression predicts lower microfoam volume use with PT (B = −0.4; <em>P</em> = .003) and similar treatment success rates when correct
{"title":"Proximal tumescence during treatment of saphenous veins with polidocanol endovenous microfoam provides successful ablation of larger veins and predicts reduced microfoam volume","authors":"Alexandra Natalie Ascher MD , Enrico Ascher MD , Anil Hingorani MD , John Fang DO","doi":"10.1016/j.jvsv.2025.102362","DOIUrl":"10.1016/j.jvsv.2025.102362","url":null,"abstract":"<div><h3>Background</h3><div>Perivenous tumescence with saline or a dilute lidocaine solution is used routinely for thermal ablation of refluxing superficial lower extremity veins to displace sensitive structures away from the thermal probe and provide better contact with the treated venous endothelium. In this study, we introduce an adjunctive technique of tumescence infiltration at the most efferent segment of refluxing saphenous veins treated with 1% polidocanol endovenous microfoam (PEM). We hypothesize that, by reducing the vein diameter, proximal tumescence (PT) prolongs apposition time of PEM to the endothelium by delaying venous outflow and microfoam propagation speed. We evaluated PT effects on vein closure and volume of PEM used as well as the incidence of superficial venous thrombosis and ablation-related thrombus extension (ARTE).</div></div><div><h3>Methods</h3><div>A single institution retrospective study was performed with PEM ablations for the above-knee great saphenous vein (GSV), below-knee GSV, and small saphenous vein (SSV) by two operators over a 12-month period. Duplex ultrasound (DUS) within 3 to 7 days after ablation followed by a serial surveillance DUS schedule were used to evaluate for vein closure, venous thrombosis, and ARTE per institutional protocol. Any treated vein segment found to be completely or partially patent with reflux after treatment was deemed an ablation failure. Demographics and outcomes of tumescent PEM (T-PEM) ablations were compared with nontumescent PEM (NT-PEM) ablations through univariate and generalized estimating equation modeling.</div></div><div><h3>Results</h3><div>Between June 2023 and May 2024, 183 adult patients (64 male, 119 female) treated with 1% PEM in 246 lower extremities (113 right, 133 left) met the study criteria. Nineteen patients without documented follow-up DUS examinations were excluded from this study. Overall, 293 ablations (23 above-knee SV, 199 below-knee GSV, 71 small saphenous vein) were performed with a mean PEM volume of 2.8 ± 0.6 mL per ablation with a combined closure rate of 91.8% (269 of 293). One hundred nineteen ablations (40.6%) were augmented with PT (mean tumescence volume, 6 ± 2.4 mL; range, 3-16 mL). Veins treated with T-PEM were significantly larger (mean vein diameter, 4.8 ± 1.3 mm) than veins treated with NT-PEM (mean vein diameter, 4.0 ± 0.9 mm; <em>P</em> < .001). There were no significant differences in patient age (<em>P</em> = .37), sex (<em>P</em> = .06), laterality (<em>P</em> = .29), preoperative Clinical-Etiology-Anatomy-Pathophysiology clinical severity scores (<em>P</em> = .34), PEM volume used (<em>P</em> = .09), venous thrombosis (<em>P</em> = .65), ARTE (<em>P</em> = .41), or rate of treatment success (<em>P</em> = .16) on univariate comparison of T-PEM and NT-PEM ablations. Generalized estimating equation regression predicts lower microfoam volume use with PT (B = −0.4; <em>P</em> = .003) and similar treatment success rates when correct","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102362"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-11-06DOI: 10.1016/j.jvsv.2025.102352
Jiayi Lai MD, Zian Xu MD, Hui Chen MD, PhD, Li Hu MD, PhD, Xiaoxi Lin MD, PhD, Xi Yang MD
Objective
The purpose of this study was to compare the efficacy and safety between two sclerosants for venous malformations (VMs), bleomycin polidocanol foam (BPF) and absolute ethanol (AE), and provide more clinical evidence for the application of BPF for VMs.
Methods
We conducted a retrospective study of 104 patients with VMs who had been treated with BPF and AE sclerotherapy. Patients were followed-up after treatment to assess clinical efficacy and complications. Clinical efficacy was independently evaluated by three experts based on pre- and post-treatment photos and magnetic resonance images. Complications were categorized according to the Society of Interventional Radiology Adverse Event Classification System.
Results
A total of 104 patients with VM were enrolled in this study, of which 53 (51%) received BPF sclerotherapy, and 51 (49%) received AE sclerotherapy. Most of the patients had head and neck VMs (n = 64; 62%), and the most common symptom was disfigurement. The number of sessions in the BPF group was significantly lower than in the AE group (1.5 vs 2.2; P < .05). The median treatment efficacy score was 3.0 for the BPF group and 2.7 for the AE group, with no significant difference between two groups. The median follow-up was 45 months for the BPF group and 33 months for the AE group, with no significant difference between two groups. Complications occurred in 11 patients in the BPF group and in 15 patients in the AE group, but there was no significant difference between the two groups. Mild adverse events occurred in 10 of 53 patients (19%) in the BPF group and 10 of 51 (20%) in the AE group. Moderate adverse events occurred in one patient (2%) in the BPF group and three patients (6%) in the AE group. Two patients (4%) in the AE group had nerve injury, evaluated as severe adverse events, whereas no patients in the BPF group did.
Conclusions
BPF has comparable treatment efficacy to AE in sclerotherapy for VMs. BPF showed a trend toward a lower rate of severe adverse events, although this difference was not statistically significant in our cohort. It could be an optimal sclerosant to treat VMs.
目的:比较博来霉素聚多醇泡沫(BPF)和无水乙醇(AE)两种硬化剂治疗静脉畸形(vm)的疗效和安全性,为BPF在vm中的应用提供更多临床依据。方法:我们对104例接受BPF和AE硬化治疗的vm患者进行了回顾性研究。治疗后随访患者,评估临床疗效及并发症。临床疗效由三位专家根据治疗前后照片和磁共振图像独立评估。并发症按照介入放射学会(SIR)不良事件分类系统进行分类。结果:104例VM患者入组,其中53例(51%)接受BPF硬化治疗,51例(49%)接受AE硬化治疗。大多数患者有头颈部vm (n=64, 62%),最常见的症状是毁容。BPF组的治疗次数明显低于AE组(1.5 vs 2.2)。结论:BPF在vm硬化治疗中的疗效与无水乙醇相当。BPF显示出严重不良事件发生率较低的趋势,尽管这种差异在我们的队列中没有统计学意义。它可能是治疗vm的最佳硬化剂。
{"title":"Comparison of bleomycin polidocanol foam versus absolute ethanol for sclerotherapy of venous malformations","authors":"Jiayi Lai MD, Zian Xu MD, Hui Chen MD, PhD, Li Hu MD, PhD, Xiaoxi Lin MD, PhD, Xi Yang MD","doi":"10.1016/j.jvsv.2025.102352","DOIUrl":"10.1016/j.jvsv.2025.102352","url":null,"abstract":"<div><h3>Objective</h3><div>The purpose of this study was to compare the efficacy and safety between two sclerosants for venous malformations (VMs), bleomycin polidocanol foam (BPF) and absolute ethanol (AE), and provide more clinical evidence for the application of BPF for VMs.</div></div><div><h3>Methods</h3><div>We conducted a retrospective study of 104 patients with VMs who had been treated with BPF and AE sclerotherapy. Patients were followed-up after treatment to assess clinical efficacy and complications. Clinical efficacy was independently evaluated by three experts based on pre- and post-treatment photos and magnetic resonance images. Complications were categorized according to the Society of Interventional Radiology Adverse Event Classification System.</div></div><div><h3>Results</h3><div>A total of 104 patients with VM were enrolled in this study, of which 53 (51%) received BPF sclerotherapy, and 51 (49%) received AE sclerotherapy. Most of the patients had head and neck VMs (n = 64; 62%), and the most common symptom was disfigurement. The number of sessions in the BPF group was significantly lower than in the AE group (1.5 vs 2.2; <em>P</em> < .05). The median treatment efficacy score was 3.0 for the BPF group and 2.7 for the AE group, with no significant difference between two groups. The median follow-up was 45 months for the BPF group and 33 months for the AE group, with no significant difference between two groups. Complications occurred in 11 patients in the BPF group and in 15 patients in the AE group, but there was no significant difference between the two groups. Mild adverse events occurred in 10 of 53 patients (19%) in the BPF group and 10 of 51 (20%) in the AE group. Moderate adverse events occurred in one patient (2%) in the BPF group and three patients (6%) in the AE group. Two patients (4%) in the AE group had nerve injury, evaluated as severe adverse events, whereas no patients in the BPF group did.</div></div><div><h3>Conclusions</h3><div>BPF has comparable treatment efficacy to AE in sclerotherapy for VMs. BPF showed a trend toward a lower rate of severe adverse events, although this difference was not statistically significant in our cohort. It could be an optimal sclerosant to treat VMs.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102352"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-28DOI: 10.1016/j.jvsv.2025.102434
Brett Cohen DO , Saran Singh MD , Nicholas Roma MD , Mary Sundo MD , Megan Pattoli DO , Mitchell Schwocho DO , Michael Durkin MD
{"title":"Thrombectomy Reduces Pulmonary Embolism Mortality But Unequal Access and Outcomes Persist by Race and Income","authors":"Brett Cohen DO , Saran Singh MD , Nicholas Roma MD , Mary Sundo MD , Megan Pattoli DO , Mitchell Schwocho DO , Michael Durkin MD","doi":"10.1016/j.jvsv.2025.102434","DOIUrl":"10.1016/j.jvsv.2025.102434","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102434"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}